Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Myriad Genetics (MYGN) over the last 16 years, with Q3 2025 value amounting to $36.0 million.

  • Myriad Genetics' Prepaid Assets rose 4754.1% to $36.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.0 million, marking a year-over-year increase of 4754.1%. This contributed to the annual value of $30.5 million for FY2024, which is 5721.65% up from last year.
  • As of Q3 2025, Myriad Genetics' Prepaid Assets stood at $36.0 million, which was up 4754.1% from $29.9 million recorded in Q2 2025.
  • Myriad Genetics' Prepaid Assets' 5-year high stood at $36.0 million during Q3 2025, with a 5-year trough of $18.1 million in Q1 2021.
  • In the last 5 years, Myriad Genetics' Prepaid Assets had a median value of $21.3 million in 2023 and averaged $23.4 million.
  • In the last 5 years, Myriad Genetics' Prepaid Assets crashed by 8127.9% in 2021 and then surged by 5721.65% in 2024.
  • Over the past 5 years, Myriad Genetics' Prepaid Assets (Quarter) stood at $21.0 million in 2021, then fell by 2.86% to $20.4 million in 2022, then dropped by 4.9% to $19.4 million in 2023, then surged by 57.22% to $30.5 million in 2024, then rose by 18.03% to $36.0 million in 2025.
  • Its Prepaid Assets was $36.0 million in Q3 2025, compared to $29.9 million in Q2 2025 and $32.4 million in Q1 2025.